Terms: = Liver cancer AND BCL9, LGS, 607, ENSG00000116128, MGC131591
156 results:
1. Prevalence and risk of nonalcoholic fatty liver disease among adult psoriatic patients: A systematic review, meta-analysis, and trial sequential analysis.
Hu J; Shao Y; Gui C; Xiao Y; Li L; Li Z
Medicine (Baltimore); 2024 May; 103(18):e38007. PubMed ID: 38701269
[TBL] [Abstract] [Full Text] [Related]
2. Diagnostic accuracy of magnetically guided capsule endoscopy with a detachable string for detecting oesophagogastric varices in adults with cirrhosis: prospective multicentre study.
Jiang X; Pan J; Xu Q; Song YH; Sun HH; Peng C; Qi XL; Qian YY; Zou WB; Yang Y; Jin SQ; Duan BS; Wu S; Chu Y; Xiao DH; Hu LJ; Cao JZ; Dai JF; Liu X; Xia T; Zhou W; Chen T; Zhou CH; Wu W; Liu SJ; Yang ZY; Wang F; Zhang L; Li CZ; Xu H; Wang JX; Wei B; Lin Y; Deng X; Qu LH; Shen YQ; Wang H; Huang YF; Bao HB; Zhang S; Li L; Shi YH; Wang XY; Zou DW; Wan XJ; Xu MD; Mao H; He CH; Li Z; Zuo XL; He SX; Xie XP; Liu J; Yang CQ; Spada C; Li ZS; Liao Z
BMJ; 2024 Mar; 384():e078581. PubMed ID: 38443074
[TBL] [Abstract] [Full Text] [Related]
3. Comparative Analysis of Subclassification Systems in Patients with Intermediate-Stage Hepatocellular Carcinoma (Barcelona Clinic liver Classification B) Receiving Systemic Therapy.
Ielasi L; Stefanini B; Conti F; Tonnini M; Tortora R; Magini G; Sacco R; Pressiani T; Trevisani F; Foschi FG; Piscaglia F; Granito A; Tovoli F
Curr Oncol; 2024 Jan; 31(1):547-557. PubMed ID: 38275831
[TBL] [Abstract] [Full Text] [Related]
4. Incidence and predictors of hepatocellular carcinoma in NAFLD without diagnosed cirrhosis: a nationwide real-world U.S. study.
Huang DQ; Tran S; Barnett S; Zou B; Yeo YH; Cheung R; Nguyen MH
Hepatol Int; 2024 Apr; 18(2):540-549. PubMed ID: 38079023
[TBL] [Abstract] [Full Text] [Related]
5. Assessing health-related quality of life among cancer survivors during systemic and radiation therapy in Bangladesh: a cancer-specific exploration.
Shahjalal M; Sultana M; Gow J; Hoque ME; Mistry SK; Hossain A; Mahumud RA
BMC Cancer; 2023 Dec; 23(1):1208. PubMed ID: 38062438
[TBL] [Abstract] [Full Text] [Related]
6. Active learning for extracting surgomic features in robot-assisted minimally invasive esophagectomy: a prospective annotation study.
Brandenburg JM; Jenke AC; Stern A; Daum MTJ; Schulze A; Younis R; Petrynowski P; Davitashvili T; Vanat V; Bhasker N; Schneider S; Mündermann L; Reinke A; Kolbinger FR; Jörns V; Fritz-Kebede F; Dugas M; Maier-Hein L; Klotz R; Distler M; Weitz J; Müller-Stich BP; Speidel S; Bodenstedt S; Wagner M
Surg Endosc; 2023 Nov; 37(11):8577-8593. PubMed ID: 37833509
[TBL] [Abstract] [Full Text] [Related]
7. Characteristics of adverse drug reactions induced by flutamide and bicalutamide: a real-world pharmacovigilance study using FAERS.
Sun Y; Xu T; Zhu S; Xu H
Expert Opin Drug Saf; 2024 Mar; 23(3):305-311. PubMed ID: 37795911
[TBL] [Abstract] [Full Text] [Related]
8. Network Pharmacology-Based Identification of Key Pharmacological Mechanism of Shen-qi-di-huang Decoction Acting on Uremia.
Zhang X; Chen XF; Chen WJ; Ding H; Zhang BX
Altern Ther Health Med; 2024 Jan; 30(1):44-50. PubMed ID: 37773677
[TBL] [Abstract] [Full Text] [Related]
9. Prediction of local tumor progression after microwave ablation for early-stage hepatocellular carcinoma with machine learning.
Ren H; An C; Fu W; Wu J; Yao W; Yu J; Liang P
J Cancer Res Ther; 2023 Aug; 19(4):978-987. PubMed ID: 37675726
[TBL] [Abstract] [Full Text] [Related]
10. Association between Gut Microbiota and Digestive System cancers: A Bidirectional Two-Sample Mendelian Randomization Study.
Xie N; Wang Z; Shu Q; Liang X; Wang J; Wu K; Nie Y; Shi Y; Fan D; Wu J
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447263
[TBL] [Abstract] [Full Text] [Related]
11. Impact of liver volumetric regeneration on survival outcomes in patients with hepatocellular carcinoma after major hepatectomy.
Nam NH; Yoh T; Hori Y; Morino K; Nishino H; Nishio T; Koyama Y; Ogiso S; Nagai K; Fukumitsu K; Uchida Y; Ito T; Ishii T; Seo S; Hata K; Taura K; Hatano E
Langenbecks Arch Surg; 2023 May; 408(1):193. PubMed ID: 37178235
[TBL] [Abstract] [Full Text] [Related]
12. Proteomic Discovery and Array-Based Validation of Biomarkers from Urinary Exosome by Supramolecular Probe.
Feng X; Jia S; Ali MM; Zhang G; Li D; Tao WA; Hu L
J Proteome Res; 2023 Jul; 22(7):2516-2524. PubMed ID: 37126797
[TBL] [Abstract] [Full Text] [Related]
13. Systemic exposure of floxuridine after hepatic arterial infusion pump chemotherapy with floxuridine in patients with resected colorectal liver metastases.
IJzerman NS; Filipe WF; Bruijn P; Buisman FE; Doorn LV; Doornebosch PG; Holster JJ; Grootscholten C; Grünhagen DJ; van Bommel CPE; Homs MYV; Kok NFM; Verhoef C; Koerkamp BG; Kuhlmann KFD; Mathijssen RHJ; Koolen SLW
Biomed Pharmacother; 2023 Jun; 162():114625. PubMed ID: 37058821
[TBL] [Abstract] [Full Text] [Related]
14. Prognostic and survival impact of bcl9 and RPS6KB1 copy number variation detected from circulating free DNA in hepatocellular carcinoma.
Youssef SS; El-Araby RE; Abbas EAE; Hassany M; Elbaz T
Expert Rev Mol Diagn; 2023 Mar; 23(3):267-278. PubMed ID: 36803362
[TBL] [Abstract] [Full Text] [Related]
15. Poly-hydroxylated bile acids and their prognostic roles in Alagille syndrome.
Wang MX; Han J; Liu T; Wang RX; Li LT; Li ZD; Yang JC; Liu LL; Lu Y; Xie XB; Gong JY; Li SY; Zhang L; Ling V; Wang JS
World J Pediatr; 2023 Jul; 19(7):652-662. PubMed ID: 36658452
[TBL] [Abstract] [Full Text] [Related]
16. Risk factors for liver-related and non-liver-related mortality following a sustained virological response after direct-acting antiviral treatment for hepatitis C virus infection in a real-world cohort.
Kozuka R; Tamori A; Enomoto M; Muto-Yukawa Y; Odagiri N; Kotani K; Motoyama H; Kawamura E; Hagihara A; Fujii H; Uchida-Kobayashi S; Kawada N
J Viral Hepat; 2023 May; 30(5):374-385. PubMed ID: 36583600
[TBL] [Abstract] [Full Text] [Related]
17. Performance of free-breathing dynamic T1-weighted sequences in patients at risk of developing motion artifacts undergoing gadoxetic acid-enhanced liver MRI.
Park SH; Yoon JH; Park JY; Shim YS; Lee SM; Choi SJ; Nickel MD; Lee JM
Eur Radiol; 2023 Jun; 33(6):4378-4388. PubMed ID: 36512042
[TBL] [Abstract] [Full Text] [Related]
18. [Overexpression of miR-607 inhibits hepatocellular carcinoma cell growth and metastasis by down-regulating TRPC5].
Li C; Chen S; Jiang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Nov; 42(11):1587-1593. PubMed ID: 36504050
[TBL] [Abstract] [Full Text] [Related]
19. Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis.
Chen Q; Sun T; Wang G; Zhang M; Zhu Y; Shi X; Ding Z
Dis Markers; 2022; 2022():3265212. PubMed ID: 36452343
[TBL] [Abstract] [Full Text] [Related]
20. Screening for aberrantly methylated and differentially expressed genes in nonalcoholic fatty liver disease of hepatocellular carcinoma patients with cirrhosis.
Zhang G; Hou Y
World J Surg Oncol; 2022 Nov; 20(1):364. PubMed ID: 36397165
[TBL] [Abstract] [Full Text] [Related]
[Next]
